Built for the Markets that Can’t Afford to Be Wrong
Delibera.ai is pursuing a $143M ARR opportunity across 8,250 mid-market firms in financial services, legal, and medical - with proprietary architecture, provisional patents secured, and a benchmarked accuracy advantage no competitor currently matches.
The Opportunity
The mid-market is the most underserved segment in professional AI. Enterprise firms have custom deployments. Solo operators use consumer tools. The 8,250 mid-market firms sitting between those extremes - in financial services, law, and healthcare - are making high-stakes decisions daily with AI tools that weren't built for their risk tolerance. Delibera is built specifically for that gap.
We have the highest hallucination resistance of any AI system evaluated - and accuracy is the single most cited requirement across every vertical we serve.
Why Now
Three forces are converging. Regulatory pressure on AI use in financial, legal, and medical practice is accelerating - creating demand for documented, defensible AI workflows. AI hallucination incidents are producing real professional consequences - sanctions, fines, and client losses that are driving firms toward verified alternatives. And mid-market adoption curves in financial services are steepening fast, with 91% of financial firms already assessing or deploying AI.
Delibera's multi-model deliberation architecture - grounded in MIT research and protected by provisional patents - is positioned at the intersection of all three.
The Architecture Advantage
Most AI platforms are wrappers around a single model. Delibera is fundamentally different: an orchestration layer that deploys multiple independent AI models to debate, challenge, and verify each other's outputs - then documents the entire deliberation process for audit and defensibility. This architecture is not easily replicated. It reflects two years of product development, MIT-grounded research methodology, and provisional patent protection on core elements of the deliberation and documentation process.
The result is the only AI platform that transforms accuracy from a marketing claim into a documented, traceable output.
Delibera.ai has the highest hallucination resistance of any AI system evaluated.
Validated across financial, legal, and medical use cases
Grounded in MIT multi-agent deliberation research
Protected by provisional patents
Market Snapshot
Financial services represents the largest near-term opportunity, with the shortest sales cycles and the highest existing AI adoption rates in our target segment. Legal represents a parallel opportunity with powerful urgency drivers - documented sanctions, bar referrals, and client losses from AI hallucination are accelerating purchasing decisions. Medical is our third-horizon vertical, with the highest average deal value and the longest procurement cycle.
What We're Building Toward
Delibera is actively scaling its go-to-market across financial services and legal, with medical as the next horizon. Upcoming hires include a Head of Sales, Head of Product, and Fractional CFO - roles that signal the transition from early traction to structured growth. We are currently briefing accredited investors and strategic partners who share our conviction that accuracy, defensibility, and professional-grade AI are not a niche - they're the market.
Detailed market intelligence, sector penetration modeling, and full financial projections are available to qualified investors and strategic partners under NDA.